Adventrx Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Adventrx Pharmaceuticals Inc
TickerSVRA
CIK #0001160308
CUSIP805111101
SectorLife Sciences - Pharmaceutical Preparations
Address12390 El Camino Real Suite 150, San Diego, CA 92130
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Savara Inc 2020-01-02 26.8 M Exemption: 506(b) · Remaining: $48,220,050 · Duration: One year or less · Commission: $1,405,946 · Revenue: Decline to Disclose
Mast Therapeutics Inc 2014-03-05 4.2 M Exemption: 506(b) · Duration: One year or less · Revenue: No Revenues
CIK Filing 2011 - 2026
[0001160308] 10-K
[0001160308] 10-Q
[0001160308] 3
[0001160308] 4
[0001160308] 8-K
[0001160308] D
[0001160308] SC 13D
[0001160308] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
BlackRock Inc Savara Inc [2026-01-21] 0.0
Nantahala Capital Management LLC Savara Inc [2025-11-14] 0.0
Flynn James E Savara Inc [2025-11-05] 0.0
Venrock Healthcare Capital Partners III LP Savara Inc [2025-07-08] 0.0
Vestal Point Capital LP Savara Inc [2025-02-14] 0.0
Frazier Life Sciences Public Fund LP Savara Inc [2024-11-27] 8194.0
Wellington Management Group LLP Savara Inc [2024-11-08] 5.24
BlackRock Inc Savara Inc [2024-11-08] 5.7
BlackRock Inc Savara Inc [2024-10-24] 5.7
Prudential Financial Inc Savara Inc [2024-02-13] 7.23
Jennison Associates LLC Savara Inc [2024-02-08] 6.5
BlackRock Inc Savara Inc [2024-01-31] 5.4
TCG Crossover GP I LLC Savara Inc [2023-07-25] 7.4
Growth Equity Opportunities 17 LLC Savara Inc [2021-03-25] 24.2
Adage Capital Partners GP LLC Savara Inc [2021-03-25] 6.53
Caxton Corp Savara Inc [2021-03-19] 6.2
BlackRock Inc Savara Inc [2021-02-02] 5.6
EcoR1 Capital LLC Savara Inc [2020-01-06] 8.3
Bain Capital Life Sciences Fund II LP Savara Inc [2019-12-30] 0.99
Altium Capital Management LP Savara Inc [2019-07-22] 6.27
BlackRock Inc Savara Inc [2019-02-08] 6.3
Consonance Capital Management LP Savara Inc [2018-02-14] 8.51
Zambon Spa Savara Inc [2017-06-29] 19.5
Farallon Capital Management LLC Savara Inc [2017-06-12] 2.2
Sabby Management LLC Mast Therapeutics Inc [2016-02-12] 6.69
Sabby Management LLC Mast Therapeutics Inc [2014-11-07] 3.67
Franklin Resources Inc Mast Therapeutics Inc [2013-07-10] 10.7
Sabby Management LLC Mast Therapeutics Inc [2013-06-25] 0.99
Great Point Partners LLC Mast Therapeutics Inc [2013-06-24] 8.77
Flynn James E Mast Therapeutics Inc [2013-06-21] 6.09
FMR LLC Adventrx Pharmaceuticals Inc [2012-02-14] 0.0
Marxe Austin W & Greenhouse David M Adventrx Pharmaceuticals Inc [2012-02-13] 7.91
Form 3/4/5 Filer 2011 - 2026
Lowrance David L
Savara Inc
McCracken Joseph S
Ramsay David A
Erickson Anne
McCabe Kathleen R
Pauls Matthew
Lutz Robert Matthew
Elam Nevan C
Hawkins Richard J
van Es-Johansson an
Wasfi Yasmine
Parker Braden C
Pratt Raymond Dennis
Sun Ricky
Mathers Edward T
Makhzoumi Mohamad
Florence Anthony A Jr
Chang Carmen
Growth Equity Opportunities 17 LLC
NEA 17 GP LLC
New Enterprise Associates 17 LP
NEA Partners 17 LP
Walker Paul Edward
Sandell Scott D
Baskett Forest
Behbahani Ali
Yang Rick
Chowdhury Badrul A
Landsman Liza
Makower Joshua
Sonsini Peter W
Neville Robert N
Jouhikainen Jaakko Taneli
Pikover YURI
Zambon Co SpA
Zambon SpA
Serenova a/S
Hood Shana
Culley Brian M
Parsley Edwin L
Roberts Brandi
Dittrich Howard
Greenleaf Peter
Emanuele Robert Martin
Gorgas Gregory D
Lief Jack
Shuster Lewis
Keran Patrick L
Vetticaden Santosh
Love Ted W
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Lowrance David L
Common Stock
2026-03-18 Tax withheld 24,174 $5.04 121,837
Lowrance David L
Stock Option (Right to Buy) · derivative
2026-03-18 Option exercise 130,650 $0.00
Lowrance David L
Common Stock
2026-03-18 Option exercise 80,684 $1.51 121,833
Lowrance David L
Stock Option (Right to Buy) · derivative
2026-03-18 Option exercise 75,000 $0.00
Lowrance David L
Common Stock
2026-03-18 Option exercise 12,500 $4.45 55,625
Lowrance David L
Common Stock
2026-03-18 Option exercise 24,850 $3.35 83,248
Lowrance David L
Stock Option (Right to Buy) · derivative
2026-03-18 Option exercise 43,063 $0.00
Lowrance David L
Common Stock
2026-03-18 Tax withheld 9,485 $5.04 47,804
Lowrance David L
Common Stock
2026-03-18 Tax withheld 31,885 $5.04 160,700
Lowrance David L
Stock Option (Right to Buy) · derivative
2026-03-18 Option exercise 80,684 $0.00
Lowrance David L
Stock Option (Right to Buy) · derivative
2026-03-18 Option exercise 12,500 $0.00
Lowrance David L
Common Stock
2026-03-18 Option exercise 130,650 $1.23 160,700
Lowrance David L
Common Stock
2026-03-18 Tax withheld 11,037 $5.04 55,626
Lowrance David L
Common Stock
2026-03-18 Tax withheld 23,661 $5.04 119,251
Lowrance David L
Common Stock
2026-03-18 Option exercise 75,000 $1.59 119,250
Lowrance David L
Stock Option (Right to Buy) · derivative
2026-03-18 Option exercise 24,850 $0.00
Lowrance David L
Common Stock
2026-03-18 Tax withheld 16,518 $5.04 83,251
Lowrance David L
Common Stock
2026-03-18 Option exercise 43,063 $1.11 47,800
McCracken Joseph S
Common Stock
2026-02-16 Option exercise 1,807 $1.76 3,180
McCracken Joseph S
Stock Option (right to buy) · derivative
2026-02-16 Option exercise 1,807 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 186 211,584,040
2025-12-31 147 201,239,985
2025-09-30 125 163,141,561
2025-06-30 123 167,700,927
2025-03-31 138 165,237,014
2024-12-31 136 162,896,286
2024-09-30 126 157,864,805
2024-06-30 133 152,479,087
2024-03-31 121 120,557,647
2023-12-31 98 122,060,522
2023-09-30 85 116,794,370
2023-06-30 78 89,179,782
Form 13F Holdings
Firm Period DFND Voting Shares
Swedbank AB [2026-06-30] DFND 715,900 715,900
Moody Aldrich Partners LLC [2026-06-30] SOLE 210,520 482,793
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 410,609 410,609
Wedge Capital Management L L P/NC [2026-06-30] SOLE 242,270 294,215
Farther Finance Advisors LLC [2026-06-30] SOLE 0 27,056
Sequoia Financial Advisors LLC [2026-06-30] SOLE 0 11,278
1620 Investment Advisors Inc [2026-06-30] SOLE 3,000 3,000
Gamma Investing LLC [2026-06-30] DFND 409 409
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com